Ensysce Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $181 | $305 |
Gross Profit | -765 | 305 | ||
EBITDA | -3,553 | 665 | -1,940 | -1,842 |
EBIT | -3,576 | 644 | -1,955 | -3,685 |
Net Income | -3,564 | 661 | -1,967 | -3,116 |
Net Change In Cash | 0 | 0 | 181 | 305 |
Free Cash Flow | -764 | -1,020 | -2,309 | -3,408 |
Cash | 3,502 | 4,153 | 1,043 | 3,404 |
Basic Shares | 1,229 | 2,005 | 2,005 | 2,005 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $2,230 | $2,523 | $3,531 |
Gross Profit | -5,356 | -17,312 | 3,531 | |
EBITDA | -6,730,134,000 | -10,718 | -24,222 | -19,870 |
EBIT | -10,718 | -24,222 | -19,870 | |
Net Income | -7,987,225,000 | -10,613 | -24,961 | -29,145 |
Net Change In Cash | 0 | 2,230 | 2,523 | 3,531 |
Free Cash Flow | -7,502,700,000 | -10,779 | -17,887 | -8,242 |
Cash | 3,502 | 1,123 | 3,147 | 12,264 |
Basic Shares | 1,746 | 2,264 | 179 | 84 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$2.90 |
2024-09-30 | $0.07 |
2024-06-30 | -$0.22 |
2024-03-31 | -$0.55 |
